NEW YORK (TheStreet) -- Bayer (BAYRY) stock closed up 0.44% to $100.20 on Friday, recovering a fraction of yesterday's losses caused by the German chemical company's bid to acquire Monsanto (MON), a St. Louis-based agricultural company.

Shares of Bayer dropped 7.74% on Thursday, shedding more than $8 off the stock's price and creating discord among shareholders.

"I had hoped that the days of such arrogant empire-building and ignorance of the actual owners of the business were at an end," John Bennett from Henderson Global Investor told Reuters.

Markus Manns, a Union Investment fund manager, said the merits of the deal are not clear and that Bayer's finances would be stretched with such a large transaction, Reuters added.

Other investors, such as UBS GAM fund manager Maximillian Anderl, would prefer if Bayer entered into a joint venture or merged with Monsanto to avoid paying a hefty premium, Reuters noted.

Shares of Monsanto closed higher by 0.96% to $101.52 this afternoon, after gaining 3.5% on Thursday.